You have 9 free searches left this month | for more free features.

City

New York (3)

Basking Ridge (1)

Commack (1)

Harrison (1)

New Brunswick (1)

New Hyde Park (1)

Rockville Centre (1)

Sleepy Hollow (1)

Syracuse (1)

Condition

Multiple Myeloma (3)

Refractory Multiple Myeloma (1)

Relapse Multiple Myeloma (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (3)

Sponsor

Weill Medical College of Cornell University (2)

Memorial Sloan Kettering Cancer Center (1)

Collaborator

Celgene (1)

Celgene Corporation (1)

Janssen Scientific Affairs, LLC (1)

North Shore University Hospital (1)

Rutgers Cancer Institute of New Jersey (1)

State University of New York - Upstate Medical University (1)

Weill Medical College of Cornell University (1)

Intervention

clarithromycin (3)

dexamethasone (3)

pomalidomide (3)

daratumumab (1)

stem cell (1)

Study Documents

Intervention Type

drug (3)

procedure (1)

Funder Type

Other (3)

Study Type

Interventional (3)

(ClaPD)

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Multiple Myeloma, Refractory Multiple Myeloma, Relapse Multiple Myeloma Trial in New York (Daratumumab, Clarithromycin,

Recruiting

Multiple Myeloma
+2 more

Daratumumab
+3 more

New York, New York

Weill Cornell Medicine - Multiple Myeloma Center

Jun 8, 2022

Multiple Myeloma Trial in United States (Pomalidomide, stem cell, Dexamethasone)

Active, not recruiting

Multiple Myeloma

Pomalidomide
+3 more

Basking Ridge, New Jersey
+9 more

Jan 23, 2023

Multiple Myeloma Trial in New York (dexamethasone, clarithromycin, Pomalidomide)

Completed

Has Results

Multiple Myeloma

dexamethasone
+2 more

New York, New York

Weill Cornell Medical College

May 28, 2019